{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T21:14:04Z","timestamp":1788383644369,"version":"build-2803163510"},"reference-count":105,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,1,5]]},"DOI":"10.18632\/oncotarget.23502","type":"journal-article","created":{"date-parts":[[2017,12,21]],"date-time":"2017-12-21T05:05:02Z","timestamp":1513832702000},"page":"2445-2467","source":"Crossref","is-referenced-by-count":17,"title":["Differential expression profile of CXCR3 splicing variants is associated with thyroid neoplasia. Potential role in papillary thyroid carcinoma oncogenesis?"],"prefix":"10.18632","volume":"9","author":[{"given":"Soledad","family":"Urra","sequence":"first","affiliation":[{"name":"Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin C.","family":"Fischer","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 R.","family":"Mart\u00ednez","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loreto","family":"V\u00e9liz","sequence":"additional","affiliation":[{"name":"Department of Physiology, Faculty of Biological Sciences, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paulina","family":"Orellana","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonieta","family":"Solar","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Bohmwald","sequence":"additional","affiliation":[{"name":"Millennium Institute on Immunology and Immunotherapy, Department of Molecular Genetics and Microbiology, Faculty of Biological Science, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Kalergis","sequence":"additional","affiliation":[{"name":"Millennium Institute on Immunology and Immunotherapy, Department of Molecular Genetics and Microbiology, Faculty of Biological Science, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Millennium Institute on Immunology and Immunotherapy, Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Riedel","sequence":"additional","affiliation":[{"name":"Millennium Institute of Immunology and Immunotherapy, Department of Cell Biology, Faculty of Biological Science and Faculty of Medicine, Universidad Andr\u00e9s Bello, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alejandro H.","family":"Corval\u00e1n","sequence":"additional","affiliation":[{"name":"Advanced Center for Chronic Diseases (ACCDiS), Department of Hematology and Oncology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan C.","family":"Roa","sequence":"additional","affiliation":[{"name":"Department of Pathology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodrigo","family":"Fuentealba","sequence":"additional","affiliation":[{"name":"Institute of Biomedical Sciences, Faculty of Health Sciences, Universidad Aut\u00f3noma de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Joaquin","family":"C\u00e1ceres","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Virology, Millennium Institute of Immunology and Immunotherapy, Department of Infectious Diseases and Pediatric Immunology, School of Medicine, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcelo","family":"L\u00f3pez-Lastra","sequence":"additional","affiliation":[{"name":"Laboratory of Molecular Virology, Millennium Institute of Immunology and Immunotherapy, Department of Infectious Diseases and Pediatric Immunology, School of Medicine, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Augusto","family":"Le\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Droppelmann","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hern\u00e1n E.","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Surgical Oncology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"},{"name":"Millennium Institute on Immunology and Immunotherapy, Department of Endocrinology, Faculty of Medicine, Pontificia Universidad Cat\u00f3lica de Chile, Santiago, Chile"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,20]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.surg.2010.10.016","article-title":"Analysis of the rising incidence of thyroid cancer using the surveillance, epidemiology and end results national cancer data registry","volume":"148","author":"Wilhelm","year":"2010","journal-title":"Surgery"},{"key":"2","doi-asserted-by":"publisher","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the united states, 1973-2002","volume":"295","author":"Welch","year":"2006","journal-title":"JAMA"},{"key":"3","doi-asserted-by":"publisher","first-page":"965212","DOI":"10.1155\/2013\/965212","article-title":"Worldwide increasing incidence of thyroid cancer: update on epidemiology and risk factors","volume":"2013","author":"Vigneri","year":"2013","journal-title":"J Cancer Epidemiol"},{"key":"4","doi-asserted-by":"publisher","first-page":"2187","DOI":"10.1002\/ijc.29251","article-title":"Thyroid cancer mortality and incidence: a global overview","volume":"136","author":"Negri","year":"2015","journal-title":"Int J Cancer"},{"key":"5","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: the unexpected burden of thyroid, liver, and pancreas cancers in the united states","volume":"74","author":"Matrisian","year":"2014","journal-title":"Cancer Res"},{"key":"6","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised american thyroid association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Tuttle","year":"2009","journal-title":"Thyroid"},{"key":"7","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1089\/thy.2010.0178","article-title":"Estimating risk of recurrence in differentiated thyroid cancer after total thyroidectomy and radioactive iodine remnant ablation: using response to therapy variables to modify the initial risk estimates predicted by the new American Thyroid Association staging system","volume":"20","author":"Shaha","year":"2010","journal-title":"Thyroid"},{"key":"8","first-page":"286","article-title":"Inflammation in thyroid oncogenesis","volume":"2","author":"Melillo","year":"2012","journal-title":"Am J Cancer Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"1073","DOI":"10.1093\/carcin\/bgp127","article-title":"Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability","volume":"30","author":"Mantovani","year":"2009","journal-title":"Carcinogenesis"},{"key":"10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1210\/jcem.84.2.5443","article-title":"Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma","volume":"84","author":"Yeo","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"11","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1089\/thy.2006.0306","article-title":"Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma","volume":"17","author":"Toniolo","year":"2007","journal-title":"Thyroid"},{"key":"12","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1016\/j.jamcollsurg.2006.12.037","article-title":"Increased incidence of well-differentiated thyroid cancer associated with hashimoto thyroiditis and the role of the PI3k\/Akt pathway","volume":"204","author":"Evers","year":"2007","journal-title":"J Am Coll Surg"},{"key":"13","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.jss.2007.09.020","article-title":"Is hashimoto's thyroiditis a risk factor for papillary thyroid cancer?","volume":"150","author":"Chen","year":"2008","journal-title":"J Surg Res"},{"key":"14","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1245\/s10434-013-3363-1","article-title":"Risk of thyroid cancer in patients with thyroiditis: a population-based cohort study","volume":"21","author":"Lai","year":"2014","journal-title":"Ann Surg Oncol"},{"key":"15","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0030-6665(20)31292-5","article-title":"The relationship between hashimoto's thyroiditis, thyroid neoplasia, and primary hyperparathyroidism","volume":"23","author":"Paloyan","year":"1990","journal-title":"Otolaryngol Clin North Am"},{"key":"16","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1177\/0194599812472426","article-title":"Hashimoto's thyroiditis as a risk factor of papillary thyroid cancer may improve cancer prognosis","volume":"148","author":"Zhang","year":"2013","journal-title":"Otolaryngol Head Neck Surg"},{"key":"17","first-page":"1202","article-title":"The incidence of thyroid carcinoma in patients with hashimoto's thyroiditis and solitary cold nodules","volume":"98","author":"Paloyan","year":"1985","journal-title":"Surgery"},{"key":"18","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1016\/j.mce.2009.10.003","article-title":"Thyroid cancer and inflammation","volume":"321","author":"Melillo","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"19","doi-asserted-by":"publisher","first-page":"R85","DOI":"10.1530\/ERC-13-0431","article-title":"The role of the inflammatory microenvironment in thyroid carcinogenesis","volume":"21","author":"Ward","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"20","doi-asserted-by":"publisher","first-page":"125450","DOI":"10.1155\/2014\/125450","article-title":"Immune response in thyroid cancer: widening the boundaries","volume":"2014","author":"Ward","year":"2014","journal-title":"Scientifica (Cairo)"},{"key":"21","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF02738789","article-title":"The relationship of lymphocytic thyroiditis to the development of thyroid carcinoma","volume":"8","author":"Okayasu","year":"1997","journal-title":"Endocr Pathol"},{"key":"22","doi-asserted-by":"crossref","first-page":"495","DOI":"10.3727\/096504009789735431","article-title":"Clinical and biological relationship between chronic lymphocytic thyroiditis and papillary thyroid carcinoma","volume":"17","author":"Giovannone","year":"2009","journal-title":"Oncol Res"},{"key":"23","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1067\/msy.2099.101431","article-title":"Coexistent hashimoto's thyroiditis with papillary thyroid carcinoma: impact on presentation, management, and outcome","volume":"126","author":"Shah","year":"1999","journal-title":"Surgery"},{"key":"24","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1007\/s002680020165","article-title":"Coexisting chronic lymphocytic thyroiditis and papillary thyroid cancer revisited","volume":"25","author":"Clark","year":"2001","journal-title":"World J Surg"},{"key":"25","doi-asserted-by":"publisher","first-page":"14825","DOI":"10.1073\/pnas.0503039102","article-title":"Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene","volume":"102","author":"Bressan","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"26","doi-asserted-by":"publisher","first-page":"5958","DOI":"10.1038\/sj.onc.1207790","article-title":"Functional expression of the CXCR4 chemokine receptor is induced by RET\/PTC oncogenes and is a common event in human papillary thyroid carcinomas","volume":"23","author":"Melillo","year":"2004","journal-title":"Oncogene"},{"key":"27","doi-asserted-by":"publisher","first-page":"1068","DOI":"10.1172\/JCI22758","article-title":"The RET\/PTC-RAS-BRAF linear signaling cascade mediates the motile and mitogenic phenotype of thyroid cancer cells","volume":"115","author":"Santoro","year":"2005","journal-title":"J Clin Invest"},{"key":"28","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1677\/erc.1.00947","article-title":"RET\/PTC-induced gene expression in thyroid PCCL3 cells reveals early activation of genes involved in regulation of the immune response","volume":"12","author":"Fagin","year":"2005","journal-title":"Endocr Relat Cancer"},{"key":"29","doi-asserted-by":"publisher","first-page":"4569","DOI":"10.1038\/sj.onc.1206759","article-title":"Tyrosine kinase oncoprotein, RET\/PTC3, induces the secretion of myeloid growth and chemotactic factors","volume":"22","author":"Rothstein","year":"2003","journal-title":"Oncogene"},{"key":"30","doi-asserted-by":"publisher","first-page":"11821","DOI":"10.1158\/0008-5472.CAN-07-0899","article-title":"Biological role and potential therapeutic targeting of the chemokine receptor CXCR4 in undifferentiated thyroid cancer","volume":"67","author":"Melillo","year":"2007","journal-title":"Cancer Res"},{"key":"31","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1111\/j.1365-2265.2009.03699.x","article-title":"The tight relationship between papillary thyroid cancer, autoimmunity and inflammation: clinical and molecular studies","volume":"72","author":"Fugazzola","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"32","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1158\/1541-7786.MCR-05-0261","article-title":"Inflammation, a key event in cancer development","volume":"4","author":"Huang","year":"2006","journal-title":"Mol Cancer Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nature07205","article-title":"Cancer-related inflammation","volume":"454","author":"Balkwill","year":"2008","journal-title":"Nature"},{"key":"34","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/nrc2827","article-title":"What are the hallmarks of cancer?","volume":"10","author":"Lazebnik","year":"2010","journal-title":"Nat Rev Cancer"},{"key":"35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1189\/jlb.72.1.9","article-title":"Role of cxcl1 in tumorigenesis of melanoma","volume":"72","author":"Richmond","year":"2002","journal-title":"J Leukoc Biol"},{"key":"36","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/10428190290026259","article-title":"The role of interleukin 13 in classical hodgkin lymphoma","volume":"43","author":"Mak","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"37","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/path.3029","article-title":"The chemokine system and cancer","volume":"226","author":"Balkwill","year":"2012","journal-title":"J Pathol"},{"key":"38","doi-asserted-by":"publisher","first-page":"R144","DOI":"10.1186\/bcr627","article-title":"Expression pattern of CXC chemokine receptor-4 is correlated with lymph node metastasis in human invasive ductal carcinoma","volume":"5","author":"Nagawa","year":"2003","journal-title":"Breast Cancer Res"},{"key":"39","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1016\/j.canlet.2007.05.013","article-title":"Role of chemokines in tumor growth","volume":"256","author":"Richmond","year":"2007","journal-title":"Cancer Lett"},{"key":"40","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.cytogfr.2005.04.007","article-title":"CXC chemokines in angiogenesis","volume":"16","author":"Keane","year":"2005","journal-title":"Cytokine Growth Factor Rev"},{"key":"41","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1089\/thy.2008.0237","article-title":"The expression of monocyte chemotactic protein-1 in papillary thyroid carcinoma is correlated with lymph node metastasis and tumor recurrence","volume":"19","author":"Sonoo","year":"2009","journal-title":"Thyroid"},{"key":"42","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1016\/S0140-6736(00)04046-0","article-title":"Inflammation and cancer: back to virchow?","volume":"357","author":"Mantovani","year":"2001","journal-title":"Lancet"},{"key":"43","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S1359-6101(01)00033-8","article-title":"Chemokines in cancer","volume":"13","author":"Caux","year":"2002","journal-title":"Cytokine Growth Factor Rev"},{"key":"44","doi-asserted-by":"publisher","first-page":"1022","DOI":"10.1258\/ebm.2011.011058","article-title":"Tumor necrosis factor-\u03b1 induces epithelial-mesenchymal transition of renal cell carcinoma cells via a nuclear factor kappa B-independent mechanism","volume":"236","author":"Sun","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"45","doi-asserted-by":"crossref","first-page":"5403","DOI":"10.4049\/jimmunol.175.8.5403","article-title":"The chemokines CXCL9, CXCL10, and CXCL11 differentially stimulate g alpha i-independent signaling and actin responses in human intestinal myofibroblasts","volume":"175","author":"Ward","year":"2005","journal-title":"J Immunol"},{"key":"46","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1084\/jem.20021897","article-title":"An alternatively spliced variant of CXCR3 mediates the inhibition of endothelial cell growth induced by IP-10, Mig, and I-TAC, and acts as functional receptor for platelet factor 4","volume":"197","author":"Serio","year":"2003","journal-title":"J Exp Med"},{"key":"47","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/labinvest.3780248","article-title":"CXCR3 chemokine receptor distribution in normal and inflamed tissues: expression on activated lymphocytes, endothelial cells, and dendritic cells","volume":"81","author":"Marazuela","year":"2001","journal-title":"Lab Invest"},{"key":"48","doi-asserted-by":"publisher","first-page":"597","DOI":"10.1055\/s-0034-1382053","article-title":"IP-10 in autoimmune thyroiditis","volume":"46","author":"Antonelli","year":"2014","journal-title":"Horm Metab Res"},{"key":"49","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1210\/jc.2012-2555","article-title":"Interferon-gamma and tumor necrosis factor-alpha sustain secretion of specific CXC chemokines in human thyrocytes: a first step toward a differentiation between autoimmune and tumor-related inflammation?","volume":"98","author":"Chiovato","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"50","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1210\/er.2006-0044","article-title":"Role of chemokines in endocrine autoimmune diseases","volume":"28","author":"Romagnani","year":"2007","journal-title":"Endocr Rev"},{"key":"51","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.cyto.2010.01.009","article-title":"Interferon-alpha, -beta and -gamma induce CXCL9 and CXCL10 secretion by human thyrocytes: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"50","author":"Ferrannini","year":"2010","journal-title":"Cytokine"},{"key":"52","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.imbio.2012.08.267","article-title":"Interferon-alpha, -beta and -gamma induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor gamma agonists","volume":"218","author":"Fallahi","year":"2013","journal-title":"Immunobiology"},{"key":"53","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1677\/ERC-08-0337","article-title":"Dysregulation of secretion of CXC alpha-chemokine CXCL10 in papillary thyroid cancer: modulation by peroxisome proliferator-activated receptor-gamma agonists","volume":"16","author":"Miccoli","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"54","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1084\/jem.184.3.981","article-title":"Interferon-gamma-inducible protein 10 (IP-10) is an angiostatic factor that inhibits human non-small cell lung cancer (NSCLC) tumorigenesis and spontaneous metastases","volume":"184","author":"Strieter","year":"1996","journal-title":"J Exp Med"},{"key":"55","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.imlet.2003.10.020","article-title":"The expression of the chemokine receptor CXCR3 and its ligand, CXCL10, in human breast adenocarcinoma cell lines","volume":"92","author":"Ben-Baruch","year":"2004","journal-title":"Immunol Lett"},{"key":"56","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.cyto.2004.10.003","article-title":"Cellular characteristics of neuroblastoma cells: regulation by the ELR --CXC chemokine CXCL10 and expression of a CXCR3-like receptor","volume":"29","author":"Ben-Baruch","year":"2005","journal-title":"Cytokine"},{"key":"57","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1002\/cncr.20747","article-title":"Up-regulation of the interferon gamma (IFN-gamma)-inducible chemokines IFN-inducible T-cell alpha chemoattractant and monokine induced by IFN-gamma and of their receptor CXC receptor 3 in human renal cell carcinoma","volume":"103","author":"Ishikura","year":"2005","journal-title":"Cancer"},{"key":"58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1160\/TH07","article-title":"CXC chemokines in angiogenesis","volume":"68","author":"Strieter","year":"2000","journal-title":"J Leukoc Biol"},{"key":"59","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.semcancer.2003.10.006","article-title":"CXC chemokines in angiogenesis of cancer","volume":"14","author":"Keane","year":"2004","journal-title":"Semin Cancer Biol"},{"key":"60","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1038\/sj.mn.7800200","article-title":"Role of chemokines in angiogenesis: CXCL12\/SDF-1 and CXCR4 interaction, a key regulator of endothelial cell responses","volume":"10","author":"Oppenheim","year":"2003","journal-title":"Microcirculation"},{"key":"61","doi-asserted-by":"publisher","first-page":"781","DOI":"10.14670\/HH-11-594","article-title":"CXCR3 in carcinoma progression","volume":"30","author":"Wells","year":"2015","journal-title":"Histol Histopathol"},{"key":"62","doi-asserted-by":"publisher","first-page":"4010","DOI":"10.1158\/0008-5472.CAN-03-1757","article-title":"Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes","volume":"64","author":"Taketo","year":"2004","journal-title":"Cancer Res"},{"key":"63","doi-asserted-by":"publisher","first-page":"45098","DOI":"10.1074\/jbc.M106912200","article-title":"Expression of functional chemokine receptors CXCR3 and CXCR4 on human melanoma cells","volume":"276","author":"Teixido","year":"2001","journal-title":"J Biol Chem"},{"key":"64","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.4049\/jimmunol.167.11.6576","article-title":"A functional IFN-gamma-inducible protein-10\/CXCL10-specific receptor expressed by epithelial and endothelial cells that is neither CXCR3 nor glycosaminoglycan","volume":"167","author":"Rollins","year":"2001","journal-title":"J Immunol"},{"key":"65","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1189\/jlb.70.6.849","article-title":"Modes of action of freund's adjuvants in experimental models of autoimmune diseases","volume":"70","author":"Matthys","year":"2001","journal-title":"J Leukoc Biol"},{"key":"66","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1084\/jem.194.9.1375","article-title":"Tumor necrosis factor-dependent segmental control of MIG expression by high endothelial venules in inflamed lymph nodes regulates monocyte recruitment","volume":"194","author":"McEvoy","year":"2001","journal-title":"J Exp Med"},{"key":"67","doi-asserted-by":"publisher","first-page":"9509","DOI":"10.1158\/0008-5472.CAN-05-4345","article-title":"Ras-induced modulation of CXCL10 and its receptor splice variant CXCR3-B in MDA-MB-435 and MCF-7 cells: relevance for the development of human breast cancer","volume":"66","author":"Pal","year":"2006","journal-title":"Cancer Res"},{"key":"68","doi-asserted-by":"publisher","first-page":"36842","DOI":"10.1074\/jbc.M110.170324","article-title":"CXCR3-B can mediate growth-inhibitory signals in human renal cancer cells by down-regulating the expression of heme oxygenase-1","volume":"285","author":"Pal","year":"2010","journal-title":"J Biol Chem"},{"key":"69","first-page":"1489","article-title":"CXCR3 and its binding chemokines in myeloma cells: expression of isoforms and potential relationships with myeloma cell proliferation and survival","volume":"91","author":"Rizzoli","year":"2006","journal-title":"Haematologica"},{"key":"70","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/s10549-014-3229-7","article-title":"Divergent roles of CXCR3 isoforms in promoting cancer stem-like cell survival and metastasis","volume":"149","author":"Fulton","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"71","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1016\/j.juro.2014.01.100","article-title":"The association of CXCR3 and renal cell carcinoma metastasis","volume":"192","author":"Ichikawa","year":"2014","journal-title":"J Urol"},{"key":"72","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/bjc.2015.193","article-title":"Oncogenic CXCL10 signalling drives metastasis development and poor clinical outcome","volume":"113","author":"Khodarev","year":"2015","journal-title":"Br J Cancer"},{"key":"73","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-4598-11-3","article-title":"Altered CXCR3 isoform expression regulates prostate cancer cell migration and invasion","volume":"11","author":"Wells","year":"2012","journal-title":"Mol Cancer"},{"key":"74","doi-asserted-by":"publisher","first-page":"648","DOI":"10.1016\/j.ygyno.2011.05.034","article-title":"Differential expression patterns of CXCR3 variants and corresponding CXC chemokines in clear cell ovarian cancers and endometriosis","volume":"122","author":"Aoki","year":"2011","journal-title":"Gynecol Oncol"},{"key":"75","doi-asserted-by":"crossref","first-page":"6234","DOI":"10.4049\/jimmunol.173.10.6234","article-title":"Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping","volume":"173","author":"Strieter","year":"2004","journal-title":"J Immunol"},{"key":"76","doi-asserted-by":"publisher","first-page":"2743614","DOI":"10.1155\/2016\/2743614","article-title":"CXCR3, CCR5, and CRTH2 chemokine receptor expression in lymphocytes infiltrating thyroid nodules with coincident hashimoto's thyroiditis obtained by fine needle aspiration biopsy","volume":"2016","author":"Potlukova","year":"2016","journal-title":"J Immunol Res"},{"key":"77","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1530\/EJE-12-0903","article-title":"The association between papillary thyroid carcinoma and histologically proven hashimoto's thyroiditis: a meta-analysis","volume":"168","author":"Kim","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"78","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1182\/blood-2002-10-3293","article-title":"Involvement of CXCR4 and IL-2 in the homing and retention of human NK and NK T cells to the bone marrow and spleen of nod\/scid mice","volume":"102","author":"Peled","year":"2003","journal-title":"Blood"},{"key":"79","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1038\/84219","article-title":"Lymphocyte traffic control by chemokines","volume":"2","author":"Loetscher","year":"2001","journal-title":"Nat Immunol"},{"key":"80","first-page":"287","article-title":"CXCR3, a double-edged sword in tumor progression and angiogenesis","volume":"1836","author":"Bikfalvi","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"81","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1084\/jem.184.3.963","article-title":"Chemokine receptor specific for IP10 and mig: structure, function, and expression in activated t-lymphocytes","volume":"184","author":"Moser","year":"1996","journal-title":"J Exp Med"},{"key":"82","doi-asserted-by":"crossref","first-page":"3696","DOI":"10.1002\/(SICI)1521-4141(199811)28:11<3696::AID-IMMU3696>3.0.CO;2-W","article-title":"Lymphocyte-specific chemokine receptor CXCR3: regulation, chemokine binding and gene localization","volume":"28","author":"Moser","year":"1998","journal-title":"Eur J Immunol"},{"key":"83","doi-asserted-by":"publisher","first-page":"2437","DOI":"10.1681\/ASN.2008040394","article-title":"Calcineurin inhibitors modulate CXCR3 splice variant expression and mediate renal cancer progression","volume":"19","author":"Pal","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"84","doi-asserted-by":"publisher","first-page":"3396","DOI":"10.1158\/0008-5472.CAN-06-3087","article-title":"CXCL10 promotes invasion-related properties in human colorectal carcinoma cells","volume":"67","author":"Ben-Baruch","year":"2007","journal-title":"Cancer Res"},{"key":"85","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.juro.2008.10.063","article-title":"CXCR3-B expression correlates with tumor necrosis extension in renal cell carcinoma","volume":"181","author":"Carini","year":"2009","journal-title":"J Urol"},{"key":"86","doi-asserted-by":"publisher","first-page":"1872","DOI":"10.1016\/j.humpath.2015.08.004","article-title":"Overexpression of the chemokine receptor CXCR3 and its correlation with favorable prognosis in gastric cancer","volume":"46","author":"Yang","year":"2015","journal-title":"Hum Pathol"},{"key":"87","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.4161\/cc.8.18.9537","article-title":"Reduced proliferation and enhanced migration: two sides of the same coin? molecular mechanisms of metastatic progression by YB-1","volume":"8","author":"Sorensen","year":"2009","journal-title":"Cell Cycle"},{"key":"88","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1681\/ASN.V10122518","article-title":"Role for interactions between IP-10\/Mig and CXCR3 in proliferative glomerulonephritis","volume":"10","author":"Serio","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"89","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1681\/ASN.V13153","article-title":"IP-10 and Mig production by glomerular cells in human proliferative glomerulonephritis and regulation by nitric oxide","volume":"13","author":"Maggi","year":"2002","journal-title":"J Am Soc Nephrol"},{"key":"90","first-page":"5094","article-title":"TNF: a master switch for inflammation to cancer","volume":"13","author":"Aggarwal","year":"2008","journal-title":"Front Biosci"},{"key":"91","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1038\/nrc2628","article-title":"Tumour necrosis factor and cancer","volume":"9","author":"Balkwill","year":"2009","journal-title":"Nat Rev Cancer"},{"key":"92","doi-asserted-by":"publisher","first-page":"2020","DOI":"10.1111\/jcmm.12890","article-title":"TNF-alpha augments CXCR2 and CXCR3 to promote progression of renal cell carcinoma","volume":"20","author":"Wu","year":"2016","journal-title":"J Cell Mol Med"},{"key":"93","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.autrev.2014.10.016","article-title":"Autoimmune thyroid disorders","volume":"14","author":"Fallahi","year":"2015","journal-title":"Autoimmun Rev"},{"key":"94","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.autrev.2013.10.010","article-title":"Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases","volume":"13","author":"Fallahi","year":"2014","journal-title":"Autoimmun Rev"},{"key":"95","doi-asserted-by":"publisher","first-page":"6203","DOI":"10.1038\/onc.2010.348","article-title":"Mast cells have a protumorigenic role in human thyroid cancer","volume":"29","author":"Marone","year":"2010","journal-title":"Oncogene"},{"key":"96","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/s10555-011-9286-z","article-title":"The significant role of mast cells in cancer","volume":"30","author":"Bentrem","year":"2011","journal-title":"Cancer Metastasis Rev"},{"key":"97","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1002\/ijc.23173","article-title":"Inflammation and cancer: an ancient link with novel potentials","volume":"121","author":"Harris","year":"2007","journal-title":"Int J Cancer"},{"key":"98","first-page":"854","article-title":"Nitric oxide and oxygen radicals in infection, inflammation, and cancer","volume":"63","author":"Akaike","year":"1998","journal-title":"Biochemistry"},{"key":"99","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1186\/s13148-015-0098-9","article-title":"DNA methylation profiling of the X chromosome reveals an aberrant demethylation on CXCR3 promoter in primary biliary cirrhosis","volume":"7","author":"Liao","year":"2015","journal-title":"Clin Epigenetics"},{"key":"100","doi-asserted-by":"publisher","first-page":"2973","DOI":"10.1158\/1538-7445.AM2013-2973","article-title":"Abstract 2973: CXCR3 epigenome switches splice variants in prostate cancer","volume":"73","author":"Wells","year":"2013","journal-title":"Cancer Res"},{"key":"101","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1038\/bjc.1989.387","article-title":"Characterisation of human thyroid epithelial cells immortalisedby simian virus 40 DNA transfection","volume":"60","author":"Wynford-Thomas","year":"1989","journal-title":"Br J Cancer"},{"key":"102","doi-asserted-by":"publisher","first-page":"4331","DOI":"10.1210\/jc.2008-1102","article-title":"Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification","volume":"93","author":"Haugen","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"103","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res"},{"key":"104","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1007\/s10875-013-9883-4","article-title":"Characterization of th1- and th2-associated chemokine receptor expression in spleens of patients with immune thrombocytopenia","volume":"33","author":"Peng","year":"2013","journal-title":"J Clin Immunol"},{"key":"105","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1677\/ERC-08-0079","article-title":"Re-expression of abi3-binding protein suppresses thyroid tumor growth by promoting senescence and inhibiting invasion","volume":"15","author":"Cerutti","year":"2008","journal-title":"Endocr Relat Cancer"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23502","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,30]],"date-time":"2023-08-30T03:28:29Z","timestamp":1693366109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.23502"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,20]]},"references-count":105,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1,5]]}},"alternative-id":["23502","29416784"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.23502","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,20]]}}}